Your Health, We Care
On November 20, 2015, the U.S. Food and Drug Administration (FDA) approved Ninlaro (ixazomib) for the treatment of multiple myeloma.
On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced···【more】
Release date：2026-01-07Recommended：50
The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in c···【more】
Release date：2026-01-07Recommended：58
